LC/MS Analysis of Lipid Composition in an mRNA LNP Formulation: A Stability Study

Applications | 2024 | Agilent TechnologiesInstrumentation
LC/HRMS, LC/MS/MS, LC/MS, LC/TOF
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

Analysis of Lipid Nanoparticle Components Using an Agilent 6545XT AdvanceBio LC/Q-TOF
Stability Study of mRNA - Lipid Nanoparticles under Different Formulation and Storage Conditions
Determination of mRNA Encapsulation Efficiency with the Agilent 1290 Infinity II Bio LC System
Raw Material Identification of mRNA Lipid Nanoparticle Components with the Agilent Vaya Raman Spectrometer